基本信息
浏览量:0
职业迁徙
个人简介
POSITIONS:
Mark W. Pasmantier Professor of Hematology and Medical Oncology in Medicine
Director of NewYork-Presbyterian Hospital - Weill Cornell Medicine Healthcare Systems Cancer Program
Associate Director for Clinical Services, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine
PROFESSIONAL TRAINING:
Intern, Internal Medicine, University of Wisconsin Hospital & Clinics, Madison, Wisconsin, 1982-83
Resident, Internal Medicine, Albert Einstein College of Medicine, Bronx, New York, 1983-85
Clinical Fellow, Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York, 1985-89
Dr. Nanus is an internationally recognized leader in the treatment and care of patients with genitourinary (GU) cancers, including cancers of the prostate, kidney, bladder and testes. He is actively involved in clinical, translational and basic research in GU malignancies, serving as principle or co-investigator on a variety of clinical research trials that incorporate novel targeted therapies for his patients.
Dr. Nanus served as Chief of the Division of Hematology and Medical Oncology at Weill Cornell Medicine for 14 years prior to becoming the Director of the NewYork-Presbyterian Hospital and Weill Cornell Medicine Healthcare Systems Cancer Program. Dr. Nanus is also the Associate Director of Clinical Services for the Sandra and Edward Meyer Cancer Center. He is the recipient of numerous awards including membership in the American Society for Clinical Investigation and the American Association of Physicians.
Dr. Nanus is a graduate of the University of Illinois and the Chicago Medical School at the Rosalind Franklin University of Medicine and Science. After completing clinical training in Medicine at Albert Einstein and Medical Oncology at Memorial Sloan Kettering Cancer Center, and research training at the Sloan Kettering Institute, he was invited to join the faculty at Memorial Sloan Kettering Cancer Center in 1989. Developing a program in GU cancer, he made several important contributions to clinical and basic research in kidney and prostate cancer. He was recruited to the full-time faculty of Weill Cornell Medical College in 1998.
At Weill Cornell, Dr. Nanus helped develop the Genitourinary (GU) Oncology Research Program focused on understanding the events that contribute to the progression of urologic cancers, and on developing new and more effective therapies to treat advanced prostate, kidney and bladder cancer. As a Director of the Genitourinary Oncology Research Laboratory, he works with a unique interdepartmental team of world class clinical researchers seeking to translate research on the molecular basis of GU cancers into improved cancer treatment.
Mark W. Pasmantier Professor of Hematology and Medical Oncology in Medicine
Director of NewYork-Presbyterian Hospital - Weill Cornell Medicine Healthcare Systems Cancer Program
Associate Director for Clinical Services, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine
PROFESSIONAL TRAINING:
Intern, Internal Medicine, University of Wisconsin Hospital & Clinics, Madison, Wisconsin, 1982-83
Resident, Internal Medicine, Albert Einstein College of Medicine, Bronx, New York, 1983-85
Clinical Fellow, Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York, 1985-89
Dr. Nanus is an internationally recognized leader in the treatment and care of patients with genitourinary (GU) cancers, including cancers of the prostate, kidney, bladder and testes. He is actively involved in clinical, translational and basic research in GU malignancies, serving as principle or co-investigator on a variety of clinical research trials that incorporate novel targeted therapies for his patients.
Dr. Nanus served as Chief of the Division of Hematology and Medical Oncology at Weill Cornell Medicine for 14 years prior to becoming the Director of the NewYork-Presbyterian Hospital and Weill Cornell Medicine Healthcare Systems Cancer Program. Dr. Nanus is also the Associate Director of Clinical Services for the Sandra and Edward Meyer Cancer Center. He is the recipient of numerous awards including membership in the American Society for Clinical Investigation and the American Association of Physicians.
Dr. Nanus is a graduate of the University of Illinois and the Chicago Medical School at the Rosalind Franklin University of Medicine and Science. After completing clinical training in Medicine at Albert Einstein and Medical Oncology at Memorial Sloan Kettering Cancer Center, and research training at the Sloan Kettering Institute, he was invited to join the faculty at Memorial Sloan Kettering Cancer Center in 1989. Developing a program in GU cancer, he made several important contributions to clinical and basic research in kidney and prostate cancer. He was recruited to the full-time faculty of Weill Cornell Medical College in 1998.
At Weill Cornell, Dr. Nanus helped develop the Genitourinary (GU) Oncology Research Program focused on understanding the events that contribute to the progression of urologic cancers, and on developing new and more effective therapies to treat advanced prostate, kidney and bladder cancer. As a Director of the Genitourinary Oncology Research Laboratory, he works with a unique interdepartmental team of world class clinical researchers seeking to translate research on the molecular basis of GU cancers into improved cancer treatment.
研究兴趣
论文共 568 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Isani Singh,Bailey Vaselkiv,Emily Rencsok,Karen Autio,Deborah Enting,Alicia Morgans,Joel Nowak, Kevin Kensler,David Nanus,Robert Dreicer,Brian Lewis,Oliver Sartor,Elisabeth Heath, Phillip Kantoff,Deborah Kaye,Daniel George,Lorelei Mucci
Cancer Researchno. 6_Supplement (2024): 3410-3410
Clinical Cancer Researchno. 6 (2024): 1152-1159
Silvia Daniele Rodrigues, Isadora Ferrari Teixeira,Pier Vitale Nuzzo,Hubert Pakula,David Nanus,Massimo Loda
Cancer researchno. 6_Supplement (2024): 438-438
Journal of Clinical Oncologyno. 16_suppl (2024)
crossref(2024)
medRxiv : the preprint server for health sciences (2024)
Michael Sun,Jones Nauseef,Andrés Ricaurte Fajardo,Zachary Davidson,Joseph Thomas, Samuel Ruder,Judith Stangl-Kremser,Sandra Huicochea Castellanos,Ana Molina,Cora Sternberg,Amie Patel, Sarah Yuan,Escarleth Fernandez,Edward Fung, Vasilios Avlonitis,Elisabeth O'Dwyer,David Nanus,Joseph Osborne,Neil Bander,Scott Tagawa
Scott T. Tagawa,Charlene Thomas,Jones T. Nauseef,A. Oliver Sartor,Michael Philip Sun,Sandra Huicochea Castellanos,Andres Ricaurte Fajardo,Himisha Beltran,Francesca Demichelis,Michael Sigouros,Francesco Orlando,Ana M. Molina,Zachary Davidson,Amie Patel,Brian E. Lewis,David M. Nanus,Shankar Vallabhajosula,Neil Harrison Bander,Joseph Osborne
Journal of Clinical Oncologyno. 16_suppl (2024): 5074-5074
Jones Trevor Nauseef,Charlene Thomas,Michael Sun,Nicole Jacobs,Andres Ricaurte Fajardo, Sam Ruder,Escarleth Fernandez,Zachary Davidson,Amie Patel,A. Oliver Sartor,Shankar Vallabhajosula,Ana Molina,Cora N. Sternberg,David M. Nanus,Sandra Huicochea Castellanos,Joseph Osborne,Neil H. Bander, Timothy Perk,Scott Tagawa
CANCER RESEARCHno. 7 (2024)
Samuel Ruder,Michael Sun,Andres Ricaurte Fajardo,Jones Nauseef,Zachary Davidson,Joseph Thomas,Sandra Huicochea Castellanos,Ana Molina,Cora Sternberg,Amie Patel,Escarleth Fernandez, Sarah Yuan,Edward Fung, Vasilios Avlonitis,Elisabeth O'Dwyer,David Nanus,Joseph Osborne,Neil Bander,Scott Tagawa
Cancer Researchno. 6_Supplement (2024): 7582-7582
加载更多
作者统计
#Papers: 564
#Citation: 28168
H-Index: 83
G-Index: 162
Sociability: 8
Diversity: 3
Activity: 429
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn